Mount Sinai Medical Center of Florida’s Post

Today we celebrate #WorldDenseBreastDay as an important FDA breast density-reporting standard is now in effect. Mount Sinai’s Chief of Breast Imaging, Dr. Stuart Kaplan, is a longtime pioneer of this cause. The FDA now requires that women be told if their breasts are dense or not dense. Why? What does this mean? According to the DenseBreast-info: Forty percent of women of mammography age have dense breasts, and mammograms miss about 40% of cancers in dense breasts. Many women with dense breasts would benefit from additional screening after their mammogram. Educational events like #WorldDenseBreastDay are essential to provide women and their health providers with the information needed to decide on optimal screening. Dr. Kaplan is a pioneer when it comes to identifying dense breast tissue and creating tailored breast screenings for his patients and has been doing so for over 20 years. He was also the second physician in the entire nation to publish a study about it. Learn more about Dr. Kaplan here: https://bit.ly/3TDcSxP

To view or add a comment, sign in

Explore topics